284 related articles for article (PubMed ID: 25733953)
1. Neuroimaging-based biomarkers for treatment selection in major depressive disorder.
Dunlop BW; Mayberg HS
Dialogues Clin Neurosci; 2014 Dec; 16(4):479-90. PubMed ID: 25733953
[TBL] [Abstract][Full Text] [Related]
2. Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder.
Fonseka TM; MacQueen GM; Kennedy SH
J Affect Disord; 2018 Jun; 233():21-35. PubMed ID: 29150145
[TBL] [Abstract][Full Text] [Related]
3. Prediction of treatment outcomes in major depressive disorder.
Dunlop BW
Expert Rev Clin Pharmacol; 2015; 8(6):669-72. PubMed ID: 26289221
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.
Furey ML; Drevets WC; Szczepanik J; Khanna A; Nugent A; Zarate CA
Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25820840
[TBL] [Abstract][Full Text] [Related]
5. Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies.
Delaveau P; Jabourian M; Lemogne C; Guionnet S; Bergouignan L; Fossati P
J Affect Disord; 2011 Apr; 130(1-2):66-74. PubMed ID: 21030092
[TBL] [Abstract][Full Text] [Related]
6. Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies.
Rigucci S; Serafini G; Pompili M; Kotzalidis GD; Tatarelli R
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):165-80. PubMed ID: 19670087
[TBL] [Abstract][Full Text] [Related]
7. Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence.
Leuchter AF; Cook IA; Hunter A; Korb A
Clin EEG Neurosci; 2009 Apr; 40(2):78-83. PubMed ID: 19534301
[TBL] [Abstract][Full Text] [Related]
8. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
9. Neuroimaging in psychiatry: An update.
Abou-Saleh MT
J Psychosom Res; 2006 Sep; 61(3):289-93. PubMed ID: 16938503
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic Brain Network Biomarkers of Antidepressant Response: a Review.
Dunlop K; Talishinsky A; Liston C
Curr Psychiatry Rep; 2019 Aug; 21(9):87. PubMed ID: 31410661
[TBL] [Abstract][Full Text] [Related]
11. Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.
Phillips ML; Chase HW; Sheline YI; Etkin A; Almeida JR; Deckersbach T; Trivedi MH
Am J Psychiatry; 2015 Feb; 172(2):124-38. PubMed ID: 25640931
[TBL] [Abstract][Full Text] [Related]
12. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies.
Fu CH; Steiner H; Costafreda SG
Neurobiol Dis; 2013 Apr; 52():75-83. PubMed ID: 22659303
[TBL] [Abstract][Full Text] [Related]
13. Neural predictors of successful brief psychodynamic psychotherapy for persistent depression.
Roffman JL; Witte JM; Tanner AS; Ghaznavi S; Abernethy RS; Crain LD; Giulino PU; Lable I; Levy RA; Dougherty DD; Evans KC; Fava M
Psychother Psychosom; 2014; 83(6):364-70. PubMed ID: 25323387
[TBL] [Abstract][Full Text] [Related]
14. Resting-state connectivity predictors of response to psychotherapy in major depressive disorder.
Crowther A; Smoski MJ; Minkel J; Moore T; Gibbs D; Petty C; Bizzell J; Schiller CE; Sideris J; Carl H; Dichter GS
Neuropsychopharmacology; 2015 Jun; 40(7):1659-73. PubMed ID: 25578796
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging.
Wang L; Li K; Zhang Q; Zeng Y; Dai W; Su Y; Wang G; Tan Y; Jin Z; Yu X; Si T
Psychol Med; 2014 May; 44(7):1417-26. PubMed ID: 23942213
[TBL] [Abstract][Full Text] [Related]
16. In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.
Lener MS; Iosifescu DV
Ann N Y Acad Sci; 2015 May; 1344():50-65. PubMed ID: 25854817
[TBL] [Abstract][Full Text] [Related]
17. Regionally specific alterations in functional connectivity of the anterior cingulate cortex in major depressive disorder.
Davey CG; Harrison BJ; Yücel M; Allen NB
Psychol Med; 2012 Oct; 42(10):2071-81. PubMed ID: 22954259
[TBL] [Abstract][Full Text] [Related]
18. The effects of antidepressants on human brain as detected by imaging studies. Focus on major depression.
Bellani M; Dusi N; Yeh PH; Soares JC; Brambilla P
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1544-52. PubMed ID: 21138750
[TBL] [Abstract][Full Text] [Related]
19. Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder.
Leuchter AF; Hunter AM; Krantz DE; Cook IA
Dialogues Clin Neurosci; 2014 Dec; 16(4):525-37. PubMed ID: 25733956
[TBL] [Abstract][Full Text] [Related]
20. Brain activation predicts treatment improvement in patients with major depressive disorder.
Samson AC; Meisenzahl E; Scheuerecker J; Rose E; Schoepf V; Wiesmann M; Frodl T
J Psychiatr Res; 2011 Sep; 45(9):1214-22. PubMed ID: 21477817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
